Plasma Flt-3 ligand concentration correlated with radiation-induced bone marrow damage during local fractionated radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 2, 2003, Pages 508-515

  Huchet, Aymeri ^a,b   Belkacémi, Yazid ^c,h   Frick, Johanna ^b,d   Prat, Marie ^b,d   Muresan Kloos, Ioanna ^e   Altan, Dan ^a   Chapel, Alain ^b,d   Gorin, Norbert Claude ^b,f   Gourmelon, Patrick ^b,d   Bertho, Jean Marc ^b,d,g  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b Unite de Therapie Cellulaire   (France)

^c HÔPITAL TENON   (France)

^d Institut de Radioprotection   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f HÔPITAL SAINT ANTOINE   (France)

^g INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^h CENTRE OSCAR LAMBRET   (France)

Author keywords

Biomarker; Bone marrow damage; Flt 3 ligand; Irradiation

Indexed keywords

BLOOD; BONE; CELLS; RADIOTHERAPY;

BONE MARROW (BM);

ONCOLOGY;

FLT3 LIGAND; MESSENGER RNA;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; BONE MARROW DISEASE; CANCER RADIOTHERAPY; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HODGKIN DISEASE; HUMAN; LEUKOCYTE; MALE; MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SICKNESS; SOLID TUMOR; THROMBOCYTE; TREATMENT OUTCOME;

EID: 0041881977     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00584-4     Document Type: Article

References (30)

1. Mauch P., Constine L., Greenberger J., et al. Hematopoietic stem cell compartment Acute and late effects of radiation therapy and chemotherapy . Int J Radiat Oncol Biol Phys. 31:1995;1319-1339.
2. Rosnet O., Schiff C., Pébusque M.J., et al. Human Flt3/Flk2 gene cDNA cloning and expression in hematopoietic cells . Blood. 82:1993;1110-1119.
3. Lyman S.D., James L., Johnson L., et al. Cloning of the human homologue of the murine Flt3 ligand A growth factor for early hematopoietic progenitor cells . Blood. 83:1994;2795-2801.
4. Ray R.J., Paige C.J., Furlonger C., et al. Flt3 ligand supports the differentiation of early B cell progenitors in the presence of interleukin-11 and interleukin-7. Eur J Immunol. 26:1996;1504-1510.
5. Hunte B.E., Hudak S., Campbell D., et al. Flk2/Flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors. J Immunol. 156:1995;489-496.
6. Bertho J.M., Chapel A., Loilleux S., et al. CD135 (Flk2/Flt3) expression by human thymocytes delineates a possible role of Flt3-ligand in T cell precursor proliferation and differentiation. Scand J Immunol. 52:2000;53-61.
7. + blood progenitor for anti-cancer therapy. Exp Hematol. 23:1995;1463-1471.
8. Lyman S.D., Seaberg M., Hanna R., et al. Plasma/serum levels of Flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia. Blood. 86:1995;4091-4096.
9. Wodnar-Filipowicz A., Lyman S.D., Grathwohl A., et al. Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Blood. 88:1996;4493-4499.
10. Bertho J.M., Demarquay C., Frick J., et al. Level of Flt3-ligand in plasma A new bio-indicator for radiation-induced aplasia . Int J Radiat Biol. 77:2001;703-712.
11. Hashimoto M. The distribution of active marrow in the bone of normal adult. Kiushu J Med Sci. 11:1960;103-111.
12. Cristy M. Active bone marrow distribution as a function of age in humans. Phys Med Biol. 26:1981;389-400.
13. Schmid I., Uittenbogaart C.H., Keld B., et al. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods. 170:1994;145-157.
14. Gibson U.E.M., Heid C.A., Williams P.M. A novel method for real time quantitative PCR. Genome Res. 6:1996;986-994.
15. Leutenegger C.M., Mislin C.N., Sigrist B., et al. Quantitative real-time PCR for the measurement of feline cytokine mRNA. Vet Immunol Immunopathol. 71:1999;291-305.
16. Fink L., Seeger W., Ermet L., et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med. 4:1998;1329-1333.
17. Brink N., Szamel M., Young A.R., et al. Comparative quantification of IL-1, IL-10, IL-10r, TNF and IL-7 mRNA levels in UV-irradiated skin in vivo. Inflamm Res. 49:2000;290-296.
18. Chklovskaia E., Jansen W., Nissen C., et al. Mechanism of Flt3 ligand expression in bone marrow failure Translocation from intracellular stores to the surface of T-lymphocytes after chemotherapy-induced suppression of hematopoiesis . Blood. 93:1999;2595-2603.
19. Chklovskaia E., Nissen C., Landmann L., et al. Cell surface trafficking and release of Flt3 ligand from T lymphocytes is induced by common cytokine receptor γ-chain signaling and inhibited by Cyclosporin A. Blood. 97:2001;1027-1034.
20. Todd G., Haug J.S., Bremmer D., et al. Flt3 ligand levels vary before and during G-CSF mobilization. [Abstract] Blood. 90:(10 Suppl. 1):1997;221a.
21. Nakagawa M., Terashima T., D'yachkova Y., et al. Glucocorticoid-induced granulocytosis Contribution of marrow release and demargination of intravascular granulocytes . Circulation. 98:1998;2307-2313.
22. Tobler A., Meier R., Seitz M., et al. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood. 79:1992;45-51.
23. van de Berg B.C., Malghem J., Lecouvet F.E., et al. Fat conversion of femoral marrow in glucocorticoid-treated patients A cross-sectional and longitudinal study with magnetic resonance imaging . Arthritis Rheum. 42:1999;1405-1411.
24. Solanilla A., Grosset C., Lemercier C., et al. Expression of Flt3-ligand by the endothelial cell. Leukemia. 14:2000;153-162.
25. Pisarev V.M., Parajuli P., Mosley R.L., et al. Flt-3 ligand enhances the immunogenicity of a GAG-based HIV-1 vaccine. Int J Immunopharmacol. 22:2000;865-876.
26. Laporte J.P., Bertho J.M., Frick J., et al. Flt3-ligand (Flt3-l) plasma level as a predictive indicator of bone marrow recovery after high dose chemotherapy (HDCT) and/or total body irradiation (TBI) preconditioning regimen. [Abstract] Blood. 96:2000;394a.
27. Blumenthal R.D., Lew W., Juweid M., et al. Plasma Flt-L levels predict bone marrow recovery from myelosuppressive therapy. Cancer. 88:2000;333-343.
28. Dutreix J., Girinsky T., Cosset J.M., et al. Blood cell kinetics and total body irradiation. Radiother Oncol. 9:1987;119-129.
29. Lisovsky M., Braun S.E., Ge Y., et al. Flt3-ligand production by human bone marrow stromal cells. Leukemia. 10:1996;1012-1018.
30. Fichelson S. The FLT3/FLK2 ligand Structure, functions and prospects . Eur Cytokine Netw. 9:2000;7-22.